Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

Jackson, D. J., Bacharier, L. B., Gergen, P. J., Gagalis, L., Calatroni, A., Wellford, S., Gill, M. A., Stokes, J., Liu, A. H., Gruchalla, R. S., Cohen, R. T., Makhija, M., Khurana Hershey, G. K., O’Connor, G. T., Pongracic, J. A., Sherenian, M. G., Rivera-Spoljaric, K., Zoratti, E. M., Teach, S. J., … Altman, M. C. (2022). Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. The Lancet, 400(10351), 502–511. https://doi.org/10.1016/s0140-6736(22)01198-9
Authors:
Daniel J Jackson
Leonard B Bacharier
Peter J Gergen
Lisa Gagalis
Agustin Calatroni
Stephanie Wellford
Michelle A Gill
Jeffrey Stokes
Andrew H Liu
Rebecca S Gruchalla
Robyn T Cohen
Melanie Makhija
Gurjit K Khurana Hershey
George T O'Connor
Jacqueline A Pongracic
Michael G Sherenian
Katherine Rivera-Spoljaric
Edward M Zoratti
Stephen J Teach
Meyer Kattan
Cullen M Dutmer
Haejin Kim
Carin Lamm
William J Sheehan
R Max Segnitz
Kimberly A Dill-McFarland
Cynthia M Visness
Patrice M Becker
James E Gern
Christine A Sorkness
William W Busse
Matthew C Altman
Affiliated Authors:
Meyer Kattan
Carin Lamm
Columbia Affiliation:
Subjects:
Asthma (MeSH)
Pulmonary Eosinophilia (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s0140-6736(22)01198-9
PMID:
35964610
DOI:
10.1016/s0140-6736(22)01198-9
Journal:
Lancet
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: